The left atrium: An overlooked prognostic tool

Abstract

Get full access to this article

View all access options for this article.

References

Jha

Garcia-Garcia

Iseki

et al.

Chronic kidney disease: Global dimension and perspectives. Lancet 2013; 382: 260–272.

Goette

Kalman

Aguinaga

et al.

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. Europace 2016; 18: 1455–1490.

Hirsh

Copeland-Halperin

Halperin

. Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: Mechanistic links and clinical inferences. J Am Coll Cardiol 2015; 65: 2239–2251.

Kottkamp

. Human atrial fibrillation substrate: Towards a specific fibrotic atrial cardiomyopathy. Eur Heart J 2013; 34: 2731–2738.

Lau

Proietti

Guiducci

et al.

Atrial fibrillation and thromboembolism in patients with chronic kidney disease. J Am Coll Cardiol 2016; 68: 1452–1464.

Park

Hsu

et al.

Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 2012; 23: 1725–1734.

Hoit

. Left atrial size and function: Role in prognosis. J Am Coll Cardiol 2014; 63: 493–505.

Gupta

Matulevicius

Ayers

et al.

Left atrial structure and function and clinical outcomes in the general population. Eur Heart J 2013; 34: 278–285.

Kadappu

Abhayaratna

Boyd

et al.

Independent echocardiographic markers of cardiovascular involvement in chronic kidney disease: The value of left atrial function and volume. J Am Soc Echocardiogr 2016; 29: 359–367.

10.

Alonso

Lopez

Matsushita

et al.

Chronic kidney disease is associated with the incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123: 2946–2953.

11.

Marcos EG, Geelhoed B, Van der Harst P, et al. Relation of renal dysfunction with incident atrial fibrillation and cardiovascular morbidity and mortality: The PREVEND study. Europace 2016. DOI:10.1093/europace/euw373.

12.

Emdin CA, Anderson SG, Salimi-Khorshidi G, et al. Usual blood pressure, atrial fibrillation and vascular risk: Evidence from 4.3 million adults. Int J Epidemiol 2016. DOI:10.1093/ije/dyw053.

13.

Odutayo

Wong

Hsiao

et al.

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: Systematic review and meta-analysis. Br Med J 2016; 354: i4482–i4482.